Pegylated Interferon and Ribavirin in the Retreatment of Chronic Hepatitis C in Korea

BACKGROUND/AIMS: Pegylated interferon (peginterferon) and ribavirin is the current standard therapy for chronic hepatitis C. The aims of this study were to evaluate the efficacy of peginterferon and ribavirin and to identify predictors of a sustained virological response (SVR) to the retreatment of...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Cho, Hyun Chin, Gwak, Geum-Youn, Paik, Yong Han, Choi, Moon Seok, Lee, Joon Hyeok, Koh, Kwang Cheol, Yoo, Byung Chul, Paik, Seung Woon
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Pancreatobiliary Association; Korean Society of Gastrointestinal Cancer 2013
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3782674/
https://ncbi.nlm.nih.gov/pubmed/24073317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl.2013.7.5.585
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky